Accessibility Menu
InterCure logo

InterCure

(NASDAQ) INCR

Current Price$1.09
Market Cap$64.56M
Since IPO (2019)-57%
5 Year-85%
1 Year-30%
1 Month+24%

InterCure Financials at a Glance

Market Cap

$64.56M

Revenue (TTM)

₪243.12M

Net Income (TTM)

-₪70.93M

EPS (TTM)

-$0.20

P/E Ratio

-5.45

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$1.09

Volume

137,386.808

Open

$1.07

Previous Close

$1.09

Daily Range

$1.04 - $1.09

52-Week Range

$0.68 - $1.77

Estimated Earnings Date

Apr 29, 2026

INCR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InterCure

Industry

Pharmaceuticals

Employees

285

CEO

Alexander Rabinovitch

Headquarters

Herzliya, 4676670, IL

INCR Financials

Key Financial Metrics (TTM)

Gross Margin

21.66%

Operating Margin

-17.77%

Net Income Margin

-19.47%

Return on Equity

-8.77%

Return on Capital

1.16%

Return on Assets

-5.26%

Earnings Yield

-18.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$64.56M

Shares Outstanding

59.23M

Volume

137.39K

Avg. Volume

49.91K

Financials (TTM)

Gross Profit

₪40.61M

Operating Income

-₪72.00M

EBITDA

-₪79.49M

Operating Cash Flow

₪12.20M

Capital Expenditure

-₪3.25M

Free Cash Flow

₪8.95M

Cash & ST Invst.

₪46.68M

Total Debt

₪183.01M

InterCure Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

₪65.01M

+3.4%

Gross Profit

₪20.11M

-3.4%

Gross Margin

30.94%

N/A

Market Cap

$64.56M

N/A

Market Cap/Employee

$201.75K

N/A

Employees

320

N/A

Net Income

-₪852.00K

-218.9%

EBITDA

₪7.13M

-1.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

₪46.68M

-40.7%

Total Debt

₪183.01M

-13.4%

Accounts Receivable

₪154.47M

+194.5%

Inventory

₪108.06M

-10.2%

Long Term Debt

₪78.95M

-42.4%

Short Term Debt

₪104.06M

+40.2%

Return on Assets

-5.26%

N/A

Return on Invested Capital

-6.96%

N/A

Free Cash Flow

₪4.48M

+120.4%

Operating Cash Flow

₪6.10M

+128.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HYFTMindWalk Holdings Corp.
$1.49-0.67%
BMEABiomea Fusion, Inc.
$1.23+0.00%
CAMPCAMP4 Therapeutics Corporation
$4.36+3.81%
FBIOFortress Biotech, Inc.
$3.16+2.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.14+0.00%
NOKNokia
$13.70-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.44-0.10%
PFEPfizer
$24.72-0.01%

Questions About INCR

What is the current price of InterCure?

InterCure is trading at $1.09 per share.

What is the 52-week range for InterCure?

Over the past 52 weeks, InterCure has traded between $0.68 and $1.77.

How much debt does InterCure have?

As of the most recent reporting period, InterCure reported total debt of ₪57.42M.

How much cash does InterCure have on hand?

InterCure reported ₪15.22M in cash and cash equivalents in its most recent financial results.

What is InterCure’s dividend yield?

InterCure does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.